Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypofractionated simultaneous integrated boost (IMRT-SIB) with pelvic nodal irradiation and concurrent androgen deprivation therapy for high-risk prostate cancer: results of a prospective phase II trial.
Magli A, Moretti E, Tullio A, Giannarini G, Tonetto F, Urpis M, Crespi M, Foti C, Prisco A, Polsinelli M, De Giorgi G, Bravo G, Scalchi P, Trovò M. Magli A, et al. Among authors: trovo m. Prostate Cancer Prostatic Dis. 2018 Jun;21(2):269-276. doi: 10.1038/s41391-018-0034-0. Epub 2018 Mar 8. Prostate Cancer Prostatic Dis. 2018. PMID: 29520019 Clinical Trial.
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity.
Arcangeli S, Jereczek-Fossa BA, Alongi F, Aristei C, Becherini C, Belgioia L, Buglione M, Caravatta L, D'Angelillo RM, Filippi AR, Fiore M, Genovesi D, Greco C, Livi L, Magrini SM, Marvaso G, Mazzola R, Meattini I, Merlotti A, Palumbo I, Pergolizzi S, Ramella S, Ricardi U, Russi E, Trovò M, Sindoni A, Valentini V, Corvò R. Arcangeli S, et al. Among authors: trovo m. Crit Rev Oncol Hematol. 2019 Feb;134:104-119. doi: 10.1016/j.critrevonc.2018.11.006. Epub 2018 Nov 30. Crit Rev Oncol Hematol. 2019. PMID: 30658887 Review.
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy.
Arcangeli S, Jereczek-Fossa BA, Alongi F, Aristei C, Becherini C, Belgioia L, Buglione M, Caravatta L, D'Angelillo RM, Filippi AR, Fiore M, Genovesi D, Greco C, Livi L, Magrini SM, Marvaso G, Mazzola R, Meattini I, Merlotti A, Palumbo I, Pergolizzi S, Ramella S, Ricardi U, Russi E, Trovò M, Sindoni A, Valentini V, Corvò R. Arcangeli S, et al. Among authors: trovo m. Crit Rev Oncol Hematol. 2019 Feb;134:87-103. doi: 10.1016/j.critrevonc.2018.11.005. Epub 2018 Dec 1. Crit Rev Oncol Hematol. 2019. PMID: 30658886 Review.
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Jereczek-Fossa BA, Pepa M, Marvaso G, Bruni A, Buglione di Monale E Bastia M, Catalano G, Filippi AR, Franco P, Gambacorta MA, Genovesi D, Iatì G, Magli A, Marafioti L, Meattini I, Merlotti A, Mignogna M, Musio D, Pacelli R, Pergolizzi S, Tombolini V, Trovò M, Ricardi U, Magrini SM, Corvò R, Donato V; AIRO (Italian Association of Radiotherapy and Clinical Oncology). Jereczek-Fossa BA, et al. Among authors: trovo m. Radiother Oncol. 2020 Aug;149:89-93. doi: 10.1016/j.radonc.2020.04.061. Epub 2020 May 12. Radiother Oncol. 2020. PMID: 32413527 Free PMC article.
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2.
Jereczek-Fossa BA, Pepa M, Zaffaroni M, Marvaso G, Bruni A, Buglione di Monale E Bastia M, Catalano G, Filippi AR, Franco P, Gambacorta MA, Genovesi D, Iatì G, Magli A, Marafioti L, Meattini I, Merlotti A, Mignogna M, Musio D, Pacelli R, Pergolizzi S, Tombolini V, Trovo M, Leonardi MC, Ricardi U, Magrini SM, Corvò R, Donato V; on the behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology). Jereczek-Fossa BA, et al. Among authors: trovo m. Radiother Oncol. 2021 Feb;155:120-122. doi: 10.1016/j.radonc.2020.09.049. Epub 2020 Oct 14. Radiother Oncol. 2021. PMID: 33065185 Free PMC article. No abstract available.
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?
Alongi F, Arcangeli S, Ramella S, Giaj-Levra N, Borghetti P, D'angelillo R, Ricchetti F, Maddalo M, Mazzola R, Trovò M, Russi E, Magrini SM; on the behalf of Associazione Italiana Radioterapia Oncologica (AIRO). Alongi F, et al. Among authors: trovo m. Expert Rev Anticancer Ther. 2017 Feb;17(2):157-165. doi: 10.1080/14737140.2017.1273111. Epub 2017 Jan 5. Expert Rev Anticancer Ther. 2017. PMID: 27984919 Review.
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer.
Bruni A, Scotti V, Borghetti P, Vagge S, Cozzi S, D'Angelo E, Giaj Levra N, Fozza A, Taraborrelli M, Piperno G, Vanoni V, Sepulcri M, Trovò M, Nardone V, Lattanzi E, Bou Selman S, Bertolini F, Franceschini D, Agustoni F, Jereczek-Fossa BA, Magrini SM, Livi L, Lohr F, Filippi AR. Bruni A, et al. Among authors: trovo m. Front Oncol. 2021 Sep 28;11:744956. doi: 10.3389/fonc.2021.744956. eCollection 2021. Front Oncol. 2021. PMID: 34650927 Free PMC article.
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer.
Bruni A, Scotti V, Borghetti P, Vagge S, Cozzi S, D'Angelo E, Giaj Levra N, Fozza A, Taraborrelli M, Piperno G, Vanoni V, Sepulcri M, Trovò M, Nardone V, Lattanzi E, Bou Selman S, Bertolini F, Franceschini D, Agustoni F, Jereczek-Fossa BA, Magrini SM, Livi L, Lohr F, Filippi AR. Bruni A, et al. Among authors: trovo m. Front Oncol. 2021 Nov 16;11:802949. doi: 10.3389/fonc.2021.802949. eCollection 2021. Front Oncol. 2021. PMID: 34869046 Free PMC article.
215 results